The Gene Center at Ludwig-Maximilians-Universität München and ExpreS2ion Biotechnologies Enter a Licensing Agreement

25-Feb-2015 - ExpreS2ion Biotechnologies announced the signature of a research license agreement to provide the Gene Center at Ludwig-Maximilians-Universität München with access to its Drosophila Schneider-2 cell-based technology platform - ExpreS2 - for recombinant protein production. The stable, non-lytic ...

Horizon Discovery Announces Strategic Partnership with Promega to Develop Next-Generation Predictive Human Disease Models

09-Nov-2011 - Horizon Discovery Ltd. announced a strategic partnership agreement with Promega Corporation. The partnership centers on the delivery of endogenous gene reporting capabilities, in the form of Promega’s luciferase and HaloTag® reporter technologies, using Horizon’s proprietary homologous ...

CEVEC Pharmaceuticals Opens US Subsidiary

17-Nov-2010 - CEVEC Pharmaceuticals announced the US expansion of it’s business by founding a North American subsidiary, CEVEC Pharmaceuticals, Inc., in Potomac, Maryland, USA. Located close to Washington DC and amidst the Northeast US Bioscience Corridor, the incorporation of the new site reflects CEVEC ...

BIOTECHNICA 2010 With New Focus Topics

From biomedicine to the future of our food

04-Oct-2010 - BIOTECHNICA 2010 in Hannover will run with new focus topics and more wide-ranging coverage and showcase all the latest trends and innovations from across the world. “With its broad range of offerings BIOTECHNICA has all aspects of biotechnology fully covered”, said Stephan Ph. Kühne, a Board ...

BIOTECHNICA 2010 with new focus topics

21-Sep-2010 - BIOTECHNICA 2010 is open for business in Hannover from 5 to 7 October, with new focus topics and more wide-ranging coverage. Europe’s leading biotech and life sciences event focuses on biotech applications in the fields of medicine, pharmaceuticals, food, agriculture, manufacturing industry and ...

CEVEC Signs Global License Agreement for Human CAP-T Technology with Life Technologies

19-Aug-2010 - CEVEC Pharmaceuticals announced the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation. Under the terms of the agreement, Life Technologies and CEVEC will co-operate to offer optimized expression kits based on CEVEC’s proprietary CAP-T cells to the global ...

Thermo Fisher Scientific Announces Collaboration to Establish New Tokyo Biomarker Research Center

28-Jul-2010 - Thermo Fisher Scientific Inc. announced a collaboration that aims to introduce mass spectrometry-based workflows and technologies into Japan to advance personalized medicine and healthcare. The intent of the collaboration between Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry ...

Promosome LLC and Recopharma AB Announce Technology Partnership

21-May-2010 - Promosome LLC announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Under the terms of the agreement, Recopharma will receive Promosome development assistance and license to Promosome's Translation Enhancing Elements (TEEs) and ...

Recipharm announces its intention to acquire Cobra Biomanufacturing

18-Dec-2009 - Recipharm AB announced its intention to acquire Cobra Biomanufacturing plc, a UK-based, cGMP compliant contract manufacturer of biopharmaceuticals. This move will considerably broaden Recipharm’s biologics offering whilst providing access to new markets and technologies including the production ...

Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy

13-Oct-2009 - Medicago Inc. announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate. Medicago will work with ECBC to investigate the ...